Skip to main content
. 2023 Aug 4;11:e15752. doi: 10.7717/peerj.15752

Table 5. Comparison of clinical features between patients by AAA location.

Variables Infrarenal (n = 244) Pararenal (n = 44) Suprarenal (n = 22) P
Rupture, n (%) 24 (9.84%) 6 (13.64%) 1 (4.55%) 0.501
Age, year 72.02 ± 10.47 72.59 ± 8.75 71.23 ± 11.56 0.728
Diameter (cm) 4.63 ± 1.72 5.84 ± 1.68 4.45 ± 1.49 <0.001
HbA1c (%) 6.06 ± 0.87 6.10 ± 0.50 6.09 ± 1.27 0.969
LVEF (%) 59.84 ± 9.53 60.08 ± 8.38 62.14 ± 6.66 0.537
cTnI (ng/ml) 0.90 ± 4.60 0.40 ± 1.44 0.02 ± 0.04 0.644
BNP (pg/ml) 267.89 ± 680.62 413.03 ± 999.18 581.56 ± 1,223.93 0.441
hsCRP (mg/ml) 50.54 ± 62.00 38.87 ± 33.76 38.52 ± 48.43 0.596
Creatinine (mg/dL) 111.95 ± 79.74 130.98 ± 114.95 96.28 ± 37.09 0.236
D-dimer (mg/L) 3.87 ± 4.57 4.94 ± 5.72 3.61 ± 3.27 0.450
HDL-C (mmol/L) 1.13 ± 0.36 1.06 ± 0.28 1.09 ± 0.36 0.448
LDL-C (mmol/L) 2.47 ± 0.96 2.51 ± 0.86 2.37 ± 0.80 0.850
TG (mmol/L) 1.56 ± 1.43 1.62 ± 0.84 1.42 ± 0.74 0.842
TC (mmol/L) 4.35 ± 1.28 4.52 ± 1.18 4.33 ± 1.04 0.716
ApoA1 (g/L) 0.96 ± 0.22 0.94 ± 0.21 0.95 ± 0.26 0.905
ApoB (g/L) 0.78 ± 0.25 0.82 ± 0.23 0.78 ± 0.20 0.493
ApoB/ApoA1 0.86 ± 0.51 0.90 ± 0.28 0.91 ± 0.49 0.808